PPD Screening and Treatment: Is There Room for Improvement? A New Study at Mass General Brigham
Announcing a new CWMH study on postpartum depression screening and treatment outcomes at Mass General Brigham.
Essential Reads: Breastfeeding and Anti-Epileptic Drugs
While data are limited regarding AEDs and breastfeeding, it appears that none of the AEDs are excreted at high levels into the breast milk, nor have they been associated with high rates of adverse events in the nursing infant.
Moving Backwards? Why Doesn’t the Canadian Task Force on Preventive Health Care Recommend Standardized Screening for Perinatal Depression?
This task force does not recommend universal, instrument-based screening for perinatal depression because we lack clear evidence that screening improves outcomes.
Essential Reads: Toward a Better Understanding of the Long-Term Course of Postpartum Psychosis
Women with postpartum psychosis are at risk for recurrent illness, but we have limited data regarding risk factors for recurrence.
Weekly Roundup for JULY 8, 2022: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Understanding the Complex Relationship Between Infant Sleep and Maternal Sleep and Mental Health
Changes in maternal sleep and circadian rhythms during pregnancy are associated with infant sleep problems and maternal depression and anxiety.
Zuranolone for Postpartum Depression: Results from the SKYLARK Study
Zuranolone has antidepressant effects in women with severe PPD, observed as early as 3 days after initiation of treatment. Â
Pregnant Women with Depression: Greater Use of Cannabis and Benzodiazepines, But Not Antidepressants
Cannabis use, as well as use of benzodiazepines and sedative-hypnotic medications, was more common in women with depression.
Relapse of Bipolar Disorder During Pregnancy Increases Risk of Postpartum Illness
More that half of women with bipolar disorder relapsed during pregnancy.
Essential Reads: The Pregnancy and Lactation Labeling Rule (PLLR)
The PLLR helps to put the potential effects of the drug into perspective with the goal of providing a more individualized risk-benefit analysis.